Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Foresite Capital in the transaction. Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison LLP is advising MediPacific, Inc., while Fenwick & West LLP is advising Pardes Biosciences, Inc. in the transaction. MediPacific, Inc.,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Foresite Capital on the deal. Foresite Capital announced the formation of the fund’s fifth fund, which is comprised of...
You must be a Standard 1 Year member to access this content.
